Target intelligence / Profile preview

Ribosomal protein L35 pseudogene 4 (RPL35P4)

Target
RPL35P4
Molecular classification
Other (Pseudogene)
01

Overview

RPL35P4 is a processed pseudogene derived from the RPL35 gene, which encodes the ribosomal protein L35—a component of the large 60S ribosomal subunit responsible for protein synthesis[1][2][10]. Pseudogenes such as RPL35P4 do not produce functional proteins, and there is no evidence that RPL35P4 is expressed or has any biological, therapeutic, or disease relevance. The canonical ribosomal protein L35 participates in ribosomal structure and mRNA translation, but the pseudogene RPL35P4 is simply a nonfunctional genetic remnant, and therefore is NOT considered a therapeutic target or a functional molecular entity[2][7]. The use of RPL35P4 as a target is incorrect; if you intended to query about ribosomal protein L35 (RPL35) itself, that would be a protein-coding gene involved in the ribosome, but still not a recognized pharmaceutical target. No aliases beyond its gene symbol are typically used for pseudogenes[2]. No mechanism of action or drugs or diseases related to this pseudogene. No biomarker or safety information available. If you need information about the protein-coding gene "Ribosomal protein L35" (RPL35), which has canonical biological function, request information for RPL35 instead[1][3][11].

Other names
Ribosomal protein L35 pseudogene 4RPL35P4
02

Biological functions

Other (Does not encode a functional protein; no demonstrated biological function)

Beyond the preview

Go deeper on Ribosomal protein L35 pseudogene 4 (RPL35P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L35 pseudogene 4 (RPL35P4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call